Harish Babu MD
Associate Professor of Neurosurgery and Director of Epilepsy & Functional Neurosurgery
Join to view full profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-6148
Dr. Babu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Babu is a fellowship-trained neurosurgeon with broad clinical expertise spanning complex brain tumors, epilepsy and epilepsy surgery, functional neurosurgery, stereotactic radiosurgery, neuro-oncology, and skull base neurosurgery. He brings with him a strong record of academic and clinical leadership, most recently from his six-year appointment at SUNY Upstate Medical University in Syracuse, New York. Across these roles, Dr. Babu has demonstrated a sustained commitment to integrating advanced clinical care with rigorous translational and human neuroscience research
Education & Training
Cedars-Sinai Medical CenterResidency, Neurological Surgery, 2013 - 2019
Calicut Medical CollegeClass of 2001
Certifications & Licensure
NY State Medical License 2020 - 2027
MD State Medical License 2026 - 2026
CA State Medical License 2015 - 2021
American Board of Neurological Surgery Neurological Surgery
Publications & Presentations
PubMed
- Post-diagnosis unemployment and access to work-related health benefits in survivors of brain cancer compared to other cancers.John Dempsey, Alexandra Balshi, Adam Jiadi, Harish Babu
Supportive Care in Cancer. 2026-05-07 - Social factors related to untreated post stroke depression.Alexandra Balshi, John Dempsey, Matthew Z Farber, Adam Jiadi, Harish Babu
General Hospital Psychiatry. 2025-09-24 - 1 citationsInhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma.Somanath Kundu, Soham Mitra, Arivazhagan Roshini, John A Longo, Sharon L Longo
Cancer Research Communications. 2025-09-01
Press Mentions
Neurona Therapeutics Presents Updated Data from the NRTX-1001 Cell Therapy Trial in Adults with Drug-Resistant Focal Epilepsy at American Academy of Neurology (AAN) 2023 Annual MeetingApril 24th, 2023- First Patient Dosed in Clinical Trial for a Drug-Resistant Form of EpilepsyJuly 1st, 2022
- Neurona Therapeutics Announces Initial Subject Dosed in First Clinical Trial of Regenerative Human Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal EpilepsyJune 29th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
